YSYoshiyuki Satake

Yoshiyuki Satake

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yoshiyuki Satake has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Descemet-stripping automated endothelial keratoplasty in eyes with transscleral-sutured intraocular lenses

    by Hiroyuki Yazu, Takefumi Yamaguchi, Murat Dogru, Nobuhito Ishii, Yoshiyuki Satake, Jun Shimazaki

    Purpose To compare the clinical outcomes and complications of Descemet-stripping automated endothelial keratoplasty (DSAEK) with a transscleral-sutured intraocular lens (IOL) and solitary DSAEK. Setting Department of Ophthalmology, Tokyo Dental College, Chiba, Japan. Design Retrospective case series. Methods Cases with simultaneous transscleral-sutured IOLs or post-transscleral–sutured IOLs and solitary DSAEK cases were studied. The logMAR acuity, astigmatism, endothelial cell density (ECD), graft survival rate, and complications (eg, IOL dislocation, cystoid macular edema [CME]) were analyzed. Results Thirty-seven DSAEK cases with simultaneous transscleral-sutured IOLs or post-transscleral–sutured IOLs and 147 solitary DSAEK cases were evaluated. The logMAR corrected distance visual acuity (CDVA) improved significantly at 24 months, from 1.34 ± 0.49 (SD) to 0.48 ± 0.38 after DSAEK with transscleral-sutured IOLs and from 1.17 ± 0.69 to 0.17 ± 0.25 after solitary DSAEK. The logMAR CDVA after DSAEK with transscleral-sutured IOLs was significantly worse than that with solitary DSAEK at 6, 12, and 24 months (P < .01). The postoperative astigmatism with DSAEK with transscleral-sutured IOLs was significantly higher than with solitary DSAEK because of the larger sclerocorneal incision (P < .02). There were no significant differences in ECD or graft survival rates between DSAEK with transscleral-sutured IOLs and solitary DSAEK. The incidence of CME in DSAEK with transscleral-sutured IOLs (4/37 eyes [11%]) was higher than with solitary DSAEK (2/147 [1.4%]) (P = .02). The CME resolved with topical diclofenac and sub-Tenon injection of triamcinolone acetonide in all eyes. Conclusion The graft survival rates after DSAEK with transscleral-sutured IOLs were equivalent to those after solitary DSAEK, although the incidence of CME was higher than after solitary DSAEK. Financial Disclosure None of the authors has a financial or proprietary interest in any material or method mentioned.


    • 1 September 2015
      • Vol. 119  (9) , 625-31

    [Factors Affecting Outcomes of Repeated Penetrating Keratoplasty].

    by Shinobu Yamamoto, Machiko Shimmura-Tomita, Yoshiyuki Satake, Seika Shimazaki-Den, Shigeto Shimmura, Jun Shimazaki

    To investigate prognosis for repeated penetrating keratoplasty (PKP) and factors that affect the outcome. We retrospectively investigated graft survival rates, 1-year postoperative best-corrected visual acuity and irreversible rejection rates in 108 eyes of 106 patients that had repeated PKP. Factors that might affect the outcome were, age, number of previous PKP, original diseases, history of glaucoma and rejection and the use of postoperative immunosuppressant were also studied. Individual-factor analysis showed that history of rejection and postoperative immunosuppressant significantly increased the risk of postoperative rejection. Multi-factor analysis showed that graft survival rate was significantly lower among cases that had systemic immunosuppressants (steroids and cyclosporine). One year postoperative best-corrected visual acuity was significantly worse in cases that had history of glaucoma. In cases with history of rejection, systemic administration of postoperative immunosuppressants was significantly associated with postoperative irreversible rejection. History of rejection and glaucoma tend to have poor outcome, and the outcome might not improve by postoperative immunosuppressants.


  • Ocular Surface Reconstruction by Cultivated Epithelial Sheet Transplantation

    by Yoshiyuki Satake, Takefumi Yamaguchi, Masatoshi Hirayama, Kazunari Higa, Seika Shimazaki-Den, Murat Dogru, Tetsuya Kawakita, Motoko Kawashima, Shigeto Shimmura, Kazuo Tsubota, et al.

    Recent advances in ocular surface reconstruction for patients with severe ocular surface diseases have significantly improved the prognosis of patients with vision-impairing corneal abnormalities. The history of cultivated epithelial sheet transplantation is short, and debate on the current approaches for these procedures is continuing. Limbal stem cell transplantation, including conjunctivolimbal autograft and keratolimbal allograft, has brought opportunities for vision improvement. In addition, the use of cultivated limbal epithelial transplantation from both allogeneic and autologous sources has provided further options for immediate postoperative epithelialization of the corneal surface. Finally, cultivated oral mucosal epithelial transplantation, which allows autologous transplantation for patients with bilateral limbal stem cell deficiency, has provided the best overall midterm and long-term results. Its biggest advantages are the absence of rejection reactions and the reduction of postoperative complications associated with steroid therapy. However, a solitary surgical approach is not sufficient for obtaining a good clinical outcome. To maximize the possibility of success using these procedures, it is important to preoperatively enhance aggressive treatment of the ocular surface, especially with factors that facilitate moisture retention. In this review article, we also discuss our clinical experience in relation to these surgical procedures.


  • Immunological Rejection Following Allogeneic Cultivated Limbal Epithelial Transplantation

    by Yoshiyuki Satake, Murat Dogru, Takefumi Yamaguchi, Daisuke Tomida, Masatoshi Hirayama, Jun Shimazaki

    Allogeneic cultivated limbal epithelial transplantation (CLET), including living-related CLET, is recommended for bilateral cases with limbal stem cell deficien


  • Author reply

    by Jun Shimazaki, Ayumi Iseda, Yoshiyuki Satake, Seika Shimazaki-Den

  • Cultivated autologous limbal epithelial transplantation for symptomatic bullous keratopathy

    by Yoshiyuki Satake, Shigeto Shimmura, Jun Shimazaki

    We report the clinical outcome of cultivated autologous limbal epithelial transplantation for symptomatic bullous keratopathy in an 87-year-old female patient presenting with recurrent corneal erosion and intractable ocular pain. The patient refused corneal transplantation, and transplantation of a cultivated autologous limbal epithelial sheet was carried out to free her of the symptoms associated with chronic pseudophakic bullous keratopathy. Both integrity of transplanted epithelium and relief from intolerable ocular pain were achieved and maintained immediately after surgery. No complications were noted in either the transplanted eye or donor eye during the 43-month follow-up period. Our findings support that patients with bullous keratopathy not consenting to procedures to improve visual acuity in whom the primary aim is relief of symptoms may benefit from cultivated autologous limbal epithelial transplantation.


  • Open Access

    Barrier Function and Cytologic Features of the Ocular Surface Epithelium After Autologous Cultivated Oral Mucosal Epithelial Transplantation

    by Yoshiyuki Satake, Murat Dogru, Gen-Yuki Yamane, Shigeru Kinoshita, Kazuo Tsubota, Jun Shimazaki

    When corneal epithelium stem cells1,2 are severely damaged by inflammation or trauma, conjunctival epithelium invades the corneal surface where epithelial defects persist, resulting in limbal stem cell deficiency (LSCD).3-5 With unilateral LSCD, autologous transplantation of limbal tissues obtained from the healthy fellow eye can be used.6-9 Bilateral involvement, however, necessitates harvesting of allogenic grafts. Encouraging clinical outcomes have been reported after allogenic transplantation of limbal stem cells.10-13 However, long-term postoperative immunosuppression is necessary with this approach to prevent allograft rejection. Use of immunosuppressants incurs a high risk of infection, increased intraocular pressure, or systemic adverse effects, resulting in disappointing long-term outcomes.11,14 Recently, the clinical effectiveness of a new method of ocular surface reconstruction, autologous cultivated oral mucosal epithelial transplantation (COMET), has been reported in the treatment of patients with bilateral LSCD.15-18 The major advantage of this new approach is that it negates the need for postoperative immunosuppressive therapy. Although short-term outcomes are encouraging, long-term outcomes remain uncertain. One factor influencing long-term results is the survival of transplanted epithelial cells, which has not been reported. We studied the progress of transplanted oral mucosal epithelium by performing periodic impression cytology after COMET.